This in turn suppresses hepatic PPARα-FGF21 signaling and activates the cardiac mechanistic target of rapamycin (mTOR)/ L-type amino acid transporter 1 (LAT1) pathway, contributing to cardiac fibrosis and dysfunction.29 Here, MTOR is linked to fibrosis.